应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。
关闭
06132 华健未来-B
待上市 06-12 16:00:00
81.800
+0.000
0.00%
最高
81.800
最低
81.800
成交量
0.00
今开
81.800
昨收
81.800
日振幅
0.00%
总市值
49.08亿
流通市值
49.08亿
总股本
6,000万
成交额
0.00
换手率
0.00%
流通股本
6,000万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）
资讯
新帖
简况
华健未来（成都）科技股份有限公司首发13,600,000股H股，发售价每股81.80港元
公告速递 · 06-12 07:30
华健未来（成都）科技股份有限公司首发13,600,000股H股，发售价每股81.80港元
加载更多
公司概况
公司名称：
华健未来-B
所属市场：
SEHK
上市日期：
--
主营业务：
华健未来由多位博士共同创立,主要从事针对肿瘤,自身免疫系统疾病和代谢系统疾病创新药物的研发和生产
发行价格：
--
{"stockData":{"symbol":"06132","market":"HK","secType":"STK","nameCN":"华健未来-B","latestPrice":81.8,"timestamp":1781251200000,"preClose":81.8,"halted":9,"volume":0,"delay":0,"changeRate":0,"floatShares":59999600,"shares":59999600,"eps":0,"marketStatus":"待上市","change":0,"latestTime":"06-12 16:00:00","open":81.8,"high":81.8,"low":81.8,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1782178200000},"marketStatusCode":8,"adr":0,"listingDate":1782144000000,"exchange":"SEHK","adjPreClose":81.8,"openAndCloseTimeList":[[1781227800000,1781236800000],[1781240400000,1781251200000]],"volumeRatio":0,"ipoDetail":{"name":"华健未来－Ｂ","exchange":"SEHK","listingDate":"2026-06-23","sharesOutstanding":73599605,"sharesFloat":73599605,"offerAmount":13600000,"priceRange":"81.800","market":"HK","openProspectusDate":"2026-06-12","openProspectusUrl":"https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0612/2026061200084_c.pdf","purchaseBeginDate":"2026-06-12","purchaseEndDate":"2026-06-17","winningDate":"2026-06-22","currency":"HKD","minPurchaseQuantity":100,"peRate":-40.33,"use":"1、约80.6%或821.3百万港元将用于正在进行及计划中的管线产品临床研究及开发活动提供资金；\n2、约9.4%或95.6百万港元将用于提升研发平台以加强在免疫学、代谢和肿瘤学领域的创新管线，并开拓且开发新临床前药物以加强目前的治疗选项；\n3、约5.0%或50.9百万港元将用于逐步建立商业化团队，并随着候选药物接近商业化而扩大团队，确保产品上市时能有效拓展市场并提供支援；\n4、约5.0%或50.9百万港元将用于一般业务运营及营运资金。","industryId":"204005","industryName":"医疗保健","business":"公司由致力研发自身免疫、代谢及肿瘤学疾病的疗法的行业专家团队创立，透过识别临床需求及从预期结果倒推进行逆向工作，致力提供改良治疗解决方案。","subscribed":9.63,"marketCap":6020000000,"minimumCapital":8262.49,"overAllotment":true,"lotSize":100,"issueOpenRate":0.1,"subscribeGear":"100,200,300,400,500,600,700,800,900,1000,1500,2000,2500,3000,3500,4000,4500,5000,6000,7000,8000,9000,10000,20000,30000,40000,50000,60000,70000,80000,90000,100000,150000,200000,250000,300000,350000,400000,450000,500000,600000,680000","issueRatio":0.1,"offeringMechanism":"B"},"greyMarketDetail":{"greyDate":"2026-06-22","greyDateTimestamp":1782057600000,"greyOpeningTime":1782116100000,"greyClosingTime":1782124200000,"showGreyQuote":false,"openProspectusDate":"2026-06-12","listingDate":"2026-06-23"},"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/06132","defaultTab":"news","newsList":[{"id":"1149230137","title":"华健未来（成都）科技股份有限公司首发13,600,000股H股，发售价每股81.80港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1149230137","media":"公告速递","labels":["SGX"],"top":1,"itemType":null,"share":"https://www.laohu8.com/m/news/1149230137?lang=zh_cn&edition=full","pubTime":"2026-06-12 07:30","pubTimestamp":1781220652,"startTime":"0","endTime":"0","summary":"华健未来（成都）科技股份有限公司成立于2017年，主要从事自身免疫、代谢和肿瘤等领域创新疗法的研究与开发，现有核心产品管线包括HJ787、HJ178、HJ891等，另有HJ356、HJ093、HJ198、HJ086等多款临床前候选药物。截至2024年12月31日止年度，收入约为人民币1,800千元，研发开支约为人民币74,973千元，年内亏损及全面亏损总额约为人民币202,317千元。公司本次全球发售总数为13,600,000股H股，发售价为每股81.80港元，香港公开发售部分为1,360,000股，国际配售部分为12,240,000股。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"华健未来（成都）科技股份有限公司首发13,600,000股H股，发售价每股81.80港元","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06132"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"compareEarnings":[{"period":"1week","weight":-0.0098},{"period":"1month","weight":-0.0633},{"period":"3month","weight":-0.0294},{"period":"6month","weight":-0.0485},{"period":"1year","weight":0.0284},{"period":"ytd","weight":-0.0356}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"华健未来由多位博士共同创立,主要从事针对肿瘤,自身免疫系统疾病和代谢系统疾病创新药物的研发和生产","exchange":"SEHK","name":"华健未来-B","nameEN":"HJ SCIENCE-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"华健未来-B(06132)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供华健未来-B(06132)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"华健未来-B,06132,华健未来-B股票,华健未来-B股票老虎,华健未来-B股票老虎国际,华健未来-B行情,华健未来-B股票行情,华健未来-B股价,华健未来-B股市,华健未来-B股票价格,华健未来-B股票交易,华健未来-B股票购买,华健未来-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"华健未来-B(06132)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供华健未来-B(06132)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}